SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001019155-23-000134
Filing Date
2023-06-29
Accepted
2023-06-29 15:52:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 phaxiam424.htm 424B3 92228
  Complete submission text file 0001019155-23-000134.txt   93439
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
PHAXIAM Therapeutics S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-201279 | Film No.: 231057243
SIC: 2836 Biological Products, (No Diagnostic Substances)